Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders

被引：0
|
作者：
Francesca Marini
Francesca Giusti
Gaia Palmini
Maria Luisa Brandi
机构：
[1] Italian Foundation for the Research on Bone Diseases,Fondazione FIRMO Onlus
[2] Villa Donatello Hospital,Donatello Bone Clinic
[3] University of Florence,Department of Experimental and Clinical Biomedical Sciences
来源：
Osteoporosis International | 2023年 / 34卷
关键词：
β-Catenin; Lipoprotein receptor–related protein 5 (LPR5); Sclerostin; gene; Wnt proteins; Wnt signaling pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：213 / 238
页数：25
相关论文
共 50 条
  • [31] The expanding role of Wnt signaling in bone metabolism
    Robling, Alexander G.
    BONE, 2013, 55 (01) : 256 - 257
  • [32] High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia
    Voskaridou, Ersi
    Christoulas, Dimitrios
    Papatheodorou, Athanasios
    Bratengeier, Cornelia
    Plata, Eleni
    Kaliontzi, Despoina
    Woloszczuk, Wolfgang
    Terpos, Evangelos
    BLOOD, 2010, 116 (21) : 444 - 444
  • [33] GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders
    Cherubini, Enrico
    Ben-Ari, Yehezkel
    BRAIN SCIENCES, 2023, 13 (09)
  • [34] Wnt signaling pathway inhibitor, sclerostin, correlates with bone pain and bone marrow infiltration in patients with Gaucher disease
    Dao, Julia
    Noll, Lauren
    Friedman, Andrew
    Goker-Alpan, Ozlem
    Ivanova, Margarita
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S35 - S35
  • [35] Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders
    Pietrzyk, Barbara
    Smertka, Mike
    Chudek, Jerzy
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 26 (08): : 1283 - 1291
  • [36] BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway
    Kamiya, Nobuhiro
    Ye, Ling
    Kobayashi, Tatsuya
    Mochida, Yoshiyuki
    Yamauchi, Mitsuo
    Kronenberg, Henry M.
    Feng, Jian Q.
    Mishina, Yuji
    DEVELOPMENT, 2008, 135 (22): : 3801 - 3811
  • [37] Bone biology, signaling pathways, and therapeutic targets for osteoporosis
    Iniguez-Ariza, Nicole M.
    Clarke, Bart L.
    MATURITAS, 2015, 82 (02) : 245 - +
  • [38] Regulation of bone homeostasis: signaling pathways and therapeutic targets
    Wu, Zebin
    Li, Wenming
    Jiang, Kunlong
    Lin, Zhixiang
    Qian, Chen
    Wu, Mingzhou
    Xia, Yu
    Li, Ning
    Zhang, Hongtao
    Xiao, Haixiang
    Bai, Jiaxiang
    Geng, Dechun
    MEDCOMM, 2024, 5 (08):
  • [39] Bone-derived sclerostin and Wnt/β-catenin signaling regulate PDGFRα+ adipoprogenitor cell differentiation
    Kim, Soohyun P.
    Da, Hao
    Wang, Lei
    Taketo, Makoto M.
    Wan, Mei
    Riddle, Ryan C.
    FASEB JOURNAL, 2021, 35 (11):
  • [40] Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
    van Bezooijen, Rutger L.
    Svensson, J. Peters
    Eefting, Daniel
    Visser, Annemieke
    van der Horst, Geertje
    Karperien, Marcel
    Quax, Paul H. A.
    Vrieling, Harry
    Papapoulos, Socrates E.
    ten Dijke, Peter
    Lowik, Clemens W. G. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (01) : 19 - 28
12345